MUSTARGEN (mechlorethamine HCl for injection) prescribing information, SPL supplement 31 (2004)

Government Record · U.S. Food and Drug Administration approved labelling (NDA 006695) · February 9, 2004

U.S. Food, 2004-02-09: The FDA-approved label for mechlorethamine (Mustargen). It identifies the product as HN2, a nitrogen analogue of sulfur mustard, classifies it as an alkylating cytotoxic agent that inhibits rapidly proliferating cells, and carries a boxed warning that the drug is 'HIGHLY TOXIC'.

MUSTARGEN, an antineoplastic nitrogen mustard also known as HN2 hydrochloride, is a nitrogen analog of sulfur mustard.

p. 1 (DESCRIPTION)

U.S. Food, 2004-02-09: The FDA-approved label for mechlorethamine (Mustargen). It identifies the product as HN2, a nitrogen analogue of sulfur mustard, classifies it as an alkylating cytotoxic agent that inhibits rapidly proliferating cells, and carries a boxed warning that the drug is 'HIGHLY TOXIC'. Issuer: FDA-approved labelling. No trial funder/conflict data in a label. Comparator: none. The applicant's name does not appear in the portion of the 2004 label read; Drugs@FDA lists the current holder as Recordati Rare. The book's 'Merck' attribution is not confirmed by any document in this run – check a label copy that carries the applicant's name. Label warns (p. 1): 'This drug is HIGHLY TOXIC and both powder and solution must be handled and administered with care.' The 8-page PDF was downloaded and read from the Internet Archive copy of the FDA URL because accessdata.fda.gov was unreachable from this environment; live and archived copies are the same file. Also filed as CHI-02 (claims C1, C5). Study type: regulatory record.